This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Karperien, M. Articles by Löwik, C. W. G. M. Search for Related Content PubMed PubMed Citation Articles by Karperien, M. Articles by Löwik, C. W. G. M.

A Frame-Shift Mutation in the Type I Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor Causing Blomstrand Lethal Osteochondrodysplasia

Departments of Endocrinology and Metabolic Diseases (M.K., H.F.-S., S.E.P., C.W.G.M.L.), Pediatrics (M.K.), Clinical Genetics (S.L.J.K.), and Molecular Cell Biology (P.N.), Leiden University Medical Center, 2300 RC Leiden; the Departments of Pathology (J.J.v.d.H.) and Clinical Genetics (R.v.S.), Academic Hospital Free University, 1007 MB Amsterdam; and the Department of Obstetrics and Gynecology, Academic Hospital Rotterdam (N.S.d.H.), 3000 DR Rotterdam, The Netherlands

Address all correspondence and requests for reprints to: Dr. Marcel Karperien, Department of Endocrinology and Metabolic Diseases, Leiden University Medical Center, Building 1 C4-R, P.O. Box 9600, 2300 RC Leiden, The Netherlands. E-mail: karperien{at}rullf2.leidenuniv.nl

Blomstrand osteochondrodysplasia (BOCD) is a rare lethal skeletal dysplasia characterized by accelerated endochondral and intramembranous ossification. Comparison of the characteristics of BOCD with type I PTH/PTH-related peptide (PTHrP) receptor-ablated mice reveals striking similarities that are most prominent in the growth plate. In both cases, the growth plate is reduced in size due to a strongly diminished zone of resting cartilage and the near absence of columnar arrangement of proliferating chondrocytes. This overall similarity suggested that an inactivating mutation of the PTH/PTHrP receptor might be the underlying genetic defect causing BOCD. Indeed, inactivating mutations of the PTH/PTHrP receptor have been recently identified in two cases of BOCD.

We describe here a novel inactivating mutation in the PTH/PTHrP receptor. Sequence analysis of all coding exons of the type I PTH/PTHrP receptor gene and complementary DNA of a case with BOCD identified a homozygous point mutation in exon EL2 in which one nucleotide (G at position 1122) was absent. The mutation was inherited from both parents, supporting the autosomal recessive nature of the disease. The missense mutation resulted in a shift in the open reading frame, leading to a truncated protein that completely diverged from the wild-type sequence after amino acid 364. The mutant receptor, therefore, lacked transmembrane domains 5, 6, and 7; the connecting intra- and extracellular loops; and the cytoplasmic tail. Functional analysis of the mutant receptor in COS-7 cells and of dermal fibroblasts obtained from the case proved that the mutation was indeed inactivating. Neither the transiently transfected COS-7 cells nor the dermal fibroblasts responded to a challenge with PTH or PTHrP with a rise in intracellular cAMP levels, in sharp contrast to control cells. Our results provide further evidence that BOCD is caused by inactivating mutations of the type I PTH/PTHrP receptor and underscore the importance of this receptor in mammalian skeletal development

This article has been cited by other articles:

				J. Hoogendam, H. Farih-Sips, L. C. Wynaendts, C. W. G. M. Lowik, J. M. Wit, and M. Karperien Novel Mutations in the Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor Type 1 Causing Blomstrand Osteochondrodysplasia Types I and II J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 1088 - 1095. [Abstract] [Full Text] [PDF]

				J. Hoogendam, E. Parlevliet, R. Miclea, C. W. G. M. Lowik, J. M. Wit, and M. Karperien Novel Early Target Genes of Parathyroid Hormone-Related Peptide in Chondrocytes Endocrinology, June 1, 2006; 147(6): 3141 - 3152. [Abstract] [Full Text] [PDF]

				B. C. J. van der Eerden, M. Karperien, and J. M. Wit Systemic and Local Regulation of the Growth Plate Endocr. Rev., December 1, 2003; 24(6): 782 - 801. [Abstract] [Full Text] [PDF]

				M. Minagawa, T. Yasuda, T. Watanabe, K. Minamitani, Y. Takahashi, D. Goltzman, J. H. White, G. N. Hendy, and Y. Kohno Association between AAAG Repeat Polymorphism in the P3 Promoter of the Human Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor Gene and Adult Height, Urinary Pyridinoline Excretion, and Promoter Activity J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1791 - 1796. [Abstract] [Full Text] [PDF]

				D. W. Soegiarto, S. Kiachopoulos, E. Schipani, H. Juppner, R. G. Erben, and B. Lanske Partial Rescue of PTH/PTHrP Receptor Knockout Mice by Targeted Expression of the Jansen Transgene Endocrinology, December 1, 2001; 142(12): 5303 - 5310. [Abstract] [Full Text] [PDF]

				J. J. Wysolmerski, S. Cormier, W. M. Philbrick, P. Dann, J.-P. Zhang, J. Roume, A.-L. Delezoide, and C. Silve Absence of Functional Type 1 Parathyroid Hormone (PTH)/PTH-Related Protein Receptors in Humans Is Associated with Abnormal Breast Development and Tooth Impaction J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1788 - 1794. [Abstract] [Full Text]